What's hot at ESC Congress 2024? Join us for a comprehensive analysis of the most impactful hot line trials presented at the European Society of Cardiology (ESC) Congress 2024. In the latest episode of the View from the Thoraxcenter, Prof Nicolas van Mieghem and Dr Joost Daemen (Thoraxcenter at Erasmus MC, NL) provides an overview of the new findings and their implications for clinical practice. What should we consider when interpreting hotline data from ESC 24? How will these trials impact future research? What questions should we ask before applying the new data to clinical practice? Trials in detail covered: 00:37 RESHAPE-HF2 06:11 MATTERHORN 11:01 Tri.fr 14:43 SWEDEGRAFT 17:46 OCCUPI 22:59 REC-CAGEFREE I 28:10 SENIOR-RITA 32:58 EARTH-STEMI 35:23 POPular PAUSE TAVI 38:31 NOTION-3 44:32 RHEIA Support: This is an independent interview produced by Radcliffe Cardiology.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related